Seres Therapeutics Inc (MCRB)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 975k | -522k | 126.47M | 310k | 64k | 0 | 171k | 0 |
| Operating Income | -68.31M | -70.57M | 45.92M | -47.41M | -44.72M | -39.59M | -31.35M | -21.38M |
| Pre Tax Income | -68.8M | -71.17M | 46.55M | -47.85M | -41.25M | -40.13M | -32.87M | -37.13M |
| Net Income | -68.8M | -71.17M | 46.55M | -47.85M | -41.25M | -40.13M | -32.87M | 88.78M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -68.33M | -70.26M | 44.72M | -46.41M | -44.38M | -37.12M | -30.65M | -42.56M |
| EBITDA | -66.68M | -69.17M | 47.44M | -45.73M | -43.09M | -38.03M | -29.93M | -19.97M |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 21.77M | 32.1M | 28.27M | 34.51M | 33.22M | 146.66M | 7.13M | 126.33M |
| Operating Income | -92.84M | -91.4M | -100.28M | -71.88M | -88.13M | -64.49M | -246.49M | -107.98M |
| Pre Tax Income | -91.58M | -89.38M | -98.94M | -70.28M | -89.13M | -65.58M | -250.16M | -113.72M |
| Net Income | -91.58M | -89.38M | -98.94M | -70.28M | -89.13M | -65.58M | -250.16M | -113.72M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -2.269 | -2.203 | -2.417 | -1.002 | -0.975 | -0.714 | -1.998 | -0.88 |
| EBIT | -92.84M | -90.97M | -100.11M | -70.81M | -87.15M | -65.54M | -247.2M | -107.85M |
| EBITDA | -88.63M | -84.14M | -92.42M | -64.27M | -81.55M | -58.55M | -239.86M | -101.74M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
